Your session is about to expire
← Back to Search
Remote Monitoring and Telehealth for High Blood Pressure (vCCC 2 Trial)
vCCC 2 Trial Summary
This trial is designed to test a hypertension program that uses a virtual clinic, home monitoring, and telehealth to lower blood pressure.
vCCC 2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowvCCC 2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.vCCC 2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am on dialysis for end-stage kidney disease.I can hear well enough to follow study instructions.I can hear well enough to follow study instructions.I have high blood pressure with a reading over 140 or had a reading over 160.I can sign the consent form myself.I am currently undergoing chemotherapy.You have a long-term illness that is expected to significantly shorten your life.I am currently receiving hospice care.I cannot have my blood pressure accurately measured due to certain medical conditions or inability to follow the protocol.I am 65 years old or older.I have been diagnosed with a form of dementia.
- Group 1: Usual Care with Education
- Group 2: Virtual Collaborative Care Clinic
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the magnitude of participants involved in this research?
"Affirmative. Clinicaltrials.gov declares that this medical experiment is still recruiting participants, having originally been posted on 16th November 2021 and most recently updated 15th August 2022. The research requires 1000 individuals from a single site to partake in the trial."
Does this research endeavor have any open spots for participants?
"Affirmative. As per the information on clinicaltrials.gov, this medical investigation is actively enrolling participants. The trial was posted on November 16th 2021 and has since been updated multiple times, most recently being on August 15th 2022. This study requires 1000 individuals from a single site to participate in order for it to move forward."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger